ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 130 filers reported holding ARRAY BIOPHARMA INC in Q2 2014. The put-call ratio across all filers is 0.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $4,683,000 | +343.9% | 380,713 | +202.2% | 0.02% | +350.0% |
Q2 2017 | $1,055,000 | +5.6% | 125,993 | +12.8% | 0.00% | 0.0% |
Q1 2017 | $999,000 | -18.4% | 111,739 | -19.8% | 0.00% | -20.0% |
Q4 2016 | $1,224,000 | +41.8% | 139,267 | +9.0% | 0.01% | +25.0% |
Q3 2016 | $863,000 | +166.4% | 127,788 | +40.2% | 0.00% | +300.0% |
Q2 2016 | $324,000 | +20.4% | 91,127 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $269,000 | -31.0% | 91,127 | -1.5% | 0.00% | -50.0% |
Q4 2015 | $390,000 | -6.5% | 92,527 | +1.1% | 0.00% | 0.0% |
Q3 2015 | $417,000 | -36.8% | 91,543 | 0.0% | 0.00% | -33.3% |
Q2 2015 | $660,000 | -6.6% | 91,543 | -4.5% | 0.00% | 0.0% |
Q1 2015 | $707,000 | +56.8% | 95,884 | +0.5% | 0.00% | +50.0% |
Q4 2014 | $451,000 | +29.6% | 95,385 | -2.1% | 0.00% | +100.0% |
Q3 2014 | $348,000 | -22.0% | 97,478 | -0.4% | 0.00% | -50.0% |
Q2 2014 | $446,000 | -0.9% | 97,910 | +2.3% | 0.00% | 0.0% |
Q1 2014 | $450,000 | -22.0% | 95,753 | -16.8% | 0.00% | 0.0% |
Q4 2013 | $577,000 | -17.8% | 115,135 | +2.1% | 0.00% | -33.3% |
Q3 2013 | $702,000 | +74.2% | 112,808 | +27.1% | 0.00% | +50.0% |
Q2 2013 | $403,000 | – | 88,730 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 16,618,776 | $146,079,000 | 12.59% |
BVF INC/IL | 4,986,186 | $43,829,000 | 8.81% |
First Light Asset Management, LLC | 1,000,361 | $8,793,000 | 3.86% |
Crosspoint Capital Strategies, LLC | 463,005 | $4,070,000 | 3.62% |
Consonance Capital Management LP | 2,723,471 | $23,912,000 | 2.63% |
KOPP INVESTMENT ADVISORS LLC | 219,926 | $1,933,000 | 2.04% |
SPHERA FUNDS MANAGEMENT LTD. | 900,000 | $7,911,000 | 2.00% |
Orbimed Advisors | 16,088,800 | $141,421,000 | 1.80% |
Cormorant Asset Management, LP | 1,150,000 | $10,109,000 | 1.36% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,073,680 | $18,227,000 | 1.26% |